Rituximab-induced pneumonitis mimicking miliary tuberculosis

European Respiratory Review

Volumn 22, Issue 130, 2013, Pages 587-588

  Yao, Chih Wei ^a   Liao, Wei Chih ^a   Tu, Chih Yen ^a,b   Chen, Hung Jen ^a,c   Teseng, Guan Chin ^a   Yeh, Su Peng ^a  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; RITUXIMAB; STEROID; VINCRISTINE SULFATE; ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY;

ABDOMINAL DISTENSION; ADULT; ARTERIAL GAS; ASYMPTOMATIC DISEASE; BLOOD GAS ANALYSIS; BONE MARROW BIOPSY; BRONCHOSCOPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DYSPNEA; FEMALE; FEVER; FIBROSING ALVEOLITIS; HUMAN; HUMAN TISSUE; HYPERPLASIA; HYPOXEMIA; INTERSTITIAL LUNG DISEASE; LARGE CELL LYMPHOMA; LETTER; LUNG LAVAGE; LYMPHADENOPATHY; MILIARY TUBERCULOSIS; MULTIPLE CYCLE TREATMENT; PHYSICAL EXAMINATION; PNEUMONIA; PULSE OXIMETRY; THORAX RADIOGRAPHY; TRANSBRONCHIAL BIOPSY; BIOPSY; CHEMICALLY INDUCED; DIFFERENTIAL DIAGNOSIS; LUNG DISEASES, INTERSTITIAL; MIDDLE AGED; PREDICTIVE VALUE; TUBERCULOSIS, MILIARY; TUBERCULOSIS, PULMONARY;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC AGENTS; BIOPSY; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LUNG DISEASES, INTERSTITIAL; MIDDLE AGED; PNEUMONIA; PREDICTIVE VALUE OF TESTS; TOMOGRAPHY, X-RAY COMPUTED; TUBERCULOSIS, MILIARY; TUBERCULOSIS, PULMONARY;

EID: 84888808361     PISSN: 09059180     EISSN: 16000617     Source Type: Journal    
DOI: 10.1183/09059180.00003813     Document Type: Letter

References (5)

1. Coiffier B, Lepage E, Briere J, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 2002; 346: 235-242.
2. Liote H, Liote F, Seroussi B, et al. Rituximab-induced lung disease: a systematic literature review. Eur Respir J 2010; 35: 681-687.
3. High-resolution computed tomography findings of lung disease. In: Webb WR, Müller NL, Naidich DP, eds. High-Resolution CT of the Lung. Philadelphia, Lippincott Williams & Wilkins, 2009; p. 113.
4. Bienvenu J, Chvetzoff R, Salles G, et al. Tumor necrosis factor alpha release is a major biological event associated with rituximab treatment. Hematol J 2001; 2: 378-384.
5. Herishanu Y, Polliack A, Leider-Trejo L, et al. Fatal interstitial pneumonitis related to rituximab-containing regimen. Clin Lymphoma Myeloma 2006; 6: 407-409